USPTO Examiner FARAH AHMED M - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19211125INTERVENTIONAL NEEDLE FIXING DEVICE FOR TUMOR CLINICAL TREATMENTMay 2025August 2025Allow300NoNo
19078851SUTURING FORCEPS AND METHOD OF SUTURINGMarch 2025November 2025Allow811NoNo
19035170Suture Fastener and Delivery DeviceJanuary 2025June 2025Allow511NoNo
19029899DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTUREJanuary 2025September 2025Allow811YesNo
19030085DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTUREJanuary 2025September 2025Allow710NoNo
19030009DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTUREJanuary 2025March 2025Allow210NoNo
18966103LIGHT IRRADIATION DEVICE AND LIGHT IRRADIATION SYSTEMDecember 2024October 2025Allow1021YesNo
18918326LIGHT THERAPY DEVICE THAT TREATS A SUBJECT WITH MULTIPLE WAVELENGTHS OF LIGHTOctober 2024February 2025Allow410YesNo
18902700DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTURESeptember 2024July 2025Allow1020YesNo
18892201DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTURESeptember 2024July 2025Allow911NoNo
18814284METHODS FOR TREATING GLAUCOMAAugust 2024October 2025Allow1421YesNo
18705350TREATMENT OF NON-OCULAR DISEASES/DISORDERS BY DELIVERY OF ELECTROMAGNETIC ENERGY TO OCULAR TISSUEApril 2024May 2025Allow1221NoNo
18625610APPARATUS FOR THE TREATMENT OF GLAUCOMA USING VISIBLE AND INFRARED ULTRASHORT LASER PULSESApril 2024February 2026Allow2210NoNo
18618295OPHTHALMIC DEVICES FOR LIGHT THERAPYMarch 2024April 2025Allow1221YesNo
18595529SYSTEM AND METHOD FOR IMPROVED ELECTRONIC ASSISTED MEDICAL PROCEDURESMarch 2024August 2024Allow601NoNo
18439538SYSTEMS FOR THE TREATMENT OF GLAUCOMA USING VISIBLE AND INFRARED ULTRASHORT LASER PULSESFebruary 2024February 2025Allow1220NoNo
18400131PREPARATION OF PHOTODYNAMIC THERAPY TABLET AND METHOD FOR CONSTRUCTION AND APPLICATION OF ANTI-TUMOR MODEL FOR ENHANCED CANCER TREATMENTDecember 2023July 2024Allow610NoNo
18536119METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENSDecember 2023January 2026Allow2510YesNo
18514439BETA CONVERTER SYSTEM AND METHODS OF USENovember 2023April 2024Allow510NoNo
18505453OPTICAL FIBER DEVICE WITH SPATIALLY SELECTABLE OUTPUTNovember 2023February 2025Allow1511NoNo
18559616LIGHT APPLICATOR SYSTEM WITH PRE-PIERCING AIDNovember 2023October 2025Allow2300YesNo
18501946OPHTHALMIC TREATMENT DEVICE AND METHOD FOR DRIVING SAMENovember 2023April 2025Allow1810NoNo
18288138DEVICE FOR REAL-TIME NON-CONTACT SKIN TEMPERATURE MEASUREMENTOctober 2023March 2026Allow2920YesNo
18288150Device for Safely Cutting Biological TissuesOctober 2023November 2024Allow1320YesNo
18490825Smoke Evacuation SystemOctober 2023March 2025Allow1710NoNo
18489031HANDPIECE FOR SKIN LASER TREATMENT AND MEDICAL LASER TREATMENT APPARATUS INCLUDING THE SAMEOctober 2023March 2024Allow510NoNo
18487038OPHTHALMIC LASER DELIVERY APPARATUS USING MEMS MICROMIRROR ARRAYS FOR SCANNING AND FOCUSING LASER BEAMOctober 2023August 2025Allow2220NoNo
18482637Variable Cryosurgical Probe Planning SystemOctober 2023July 2025Allow2110YesNo
18480398SIGNAL COORDINATED DELIVERY OF LASER THERAPYOctober 2023May 2025Allow2020YesNo
18375576OPHTHALMOLOGICAL PATIENT INTERFACEOctober 2023February 2026Allow2910NoNo
18369697LASER THERAPY FOR TREATMENT AND PREVENTION OF EYE DISEASESSeptember 2023January 2026Allow2810NoNo
18457055LONG-TERM MONITORING OF THE INCISION PERFORMANCE OF AN OPHTHALMIC LASER SURGICAL SYSTEMAugust 2023December 2025Allow2710YesNo
18547487LASER FIBER OPERATORAugust 2023September 2025Allow2500NoNo
18451308INTERSTITIAL PHOTODYNAMIC THERAPYAugust 2023December 2025Allow2810NoNo
18447906ENGAGEMENT AND/OR HOMING OF A SURGICAL TOOL IN A SURGICAL ROBOTIC SYSTEMAugust 2023July 2025Allow2311NoNo
18356590METHODS AND SYSTEMS FOR THE TREATMENT OF GLAUCOMA USING VISIBLE AND INFRARED ULTRASHORT LASER PULSESJuly 2023March 2024Allow810NoNo
18350383MEDICAL DEVICE AND METHODS OF USEJuly 2023May 2025Allow2310YesNo
18219492SYSTEM AND METHODS OF UNATTENDED TREATMENTJuly 2023February 2025Allow2010NoNo
18328101ROBOTIC SURGICAL SYSTEM FOR VIRTUAL REALITY BASED ROBOTIC TELESURGICAL OPERATIONSJune 2023July 2024Allow1321YesNo
18199815PHOTOSYNTHETIC CELLULAR SUBSTANCES AND METHODS OF USE THEREOFMay 2023May 2025Allow2420NoNo
18313162METHODS FOR PHOTODYNAMIC THERAPYMay 2023January 2025Allow2010YesNo
18035040UMBILICAL ARTERIAL CATHETERIZATION DEVICEMay 2023October 2024Allow1821YesNo
18140297SYSTEMS AND METHOD FOR DELIVERING PULSED ELECTRIC CURRENT TO LIVING TISSUEApril 2023June 2025Allow2610NoNo
18140415COMBINATION TREATMENT USING ELTApril 2023September 2025Allow2820YesNo
18138606PHOTOSYNTHETIC CELLULAR SUBSTANCES AND METHODS OF USE THEREOFApril 2023December 2025Allow3230YesNo
18135368SYSTEMS AND METHODS FOR INTRAVASCULAR PROCEDURESApril 2023May 2024Allow1311NoNo
18189183DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTUREMarch 2023August 2024Allow1730YesNo
18041079INTERSTITIAL PHOTODYNAMIC THERAPYFebruary 2023June 2023Allow400NoNo
18017652ENERGY AND GASEOUS HEALTH SUPPLEMENTSJanuary 2023June 2024Allow1620YesNo
18098585PHOTOTHERAPY APPARATUSES AND METHODSJanuary 2023September 2024Allow2010NoNo
18005626SMALL PROFILE LIGHT THERAPY PROBEJanuary 2023January 2024Allow1210YesNo
17597657OPTICAL APPLICATOR FEATURE OPTIMIZERJanuary 2023September 2023Allow2010NoNo
18065546RADIATION DOSIMETRY SYSTEMS AND METHODSDecember 2022March 2025Allow2720NoNo
17989552SYSTEMS AND METHODS FOR AMBIENT ENERGY POWERED PHYSIOLOGICAL PARAMETER MONITORINGNovember 2022July 2025Allow3220YesNo
17988859SYSTEMS AND METHODS FOR CONSTRAINED SURGICAL INSTRUMENT ALIGNMENTNovember 2022March 2026Allow4020YesNo
18056316SYSTEM AND METHOD FOR IMPROVED ELECTRONIC ASSISTED MEDICAL PROCEDURESNovember 2022February 2026Abandon3901NoNo
17985899ELECTROMAGNETIC RADIATION TARGETING DEVICES, ASSEMBLIES, SYSTEMS AND METHODSNovember 2022August 2025Allow3311NoNo
17985880LIGHT-EMITTING DEVICE AND PHOTO-THERAPY DEVICE COMPRISING A LIGHT-EMITTING DEVICENovember 2022December 2024Abandon2510NoNo
17979594SURGICAL INSTRUMENT WITH ROBOTIC AND MANUAL ACTUATION FEATURESNovember 2022January 2026Abandon3821NoNo
18048296MINIMALLY INVASIVE TISSUE TREATMENT DEVICEOctober 2022April 2024Allow1831NoNo
17964740IMPLANTABLE OPTICAL STIMULATION LEAD AND METHODS OF MAKING AND USINGOctober 2022April 2025Allow3030NoNo
17964123POLARIZED LIGHT EMITTING DEVICEOctober 2022March 2024Allow1710NoNo
18045229METHODS FOR THE TREATMENT OF GLAUCOMA USING VISIBLE AND INFRARED ULTRASHORT LASER PULSESOctober 2022July 2023Allow910NoNo
17917452FLEXIBLE NONMETALLIC ELECTRODEOctober 2022July 2025Allow3310NoNo
17960464POWER CONTROL ARRANGEMENTS FOR SURGICAL INSTRUMENTS AND BATTERIESOctober 2022February 2026Allow4111NoNo
17953899SURGICAL INSTRUMENT HAVING A THENAR EMINENCE HANDLE AND METHOD FOR USE THEREOFSeptember 2022November 2023Allow1321YesNo
17951322METHOD FOR PROVIDING CONTROL DATA OF A LASER DEVICE FOR THE NON-DESTRUCTIVE LASER-INDUCED PROPERTY CHANGE OF A POLYMER STRUCTURESeptember 2022January 2026Allow4011NoNo
17899350SYSTEMS AND METHODS FOR APPLYING EXCIMER LASER ENERGY WITH TRANSVERSE PLACEMENT IN THE EYEAugust 2022November 2023Allow1520YesNo
17891447PHOTOSYNTHETIC CELLULAR SUBSTANCES AND METHODS OF USE THEREOFAugust 2022September 2025Allow3730YesNo
17889859METHODS AND SYSTEM FOR IMAGE GUIDED CELL ABLATIONAugust 2022February 2025Allow3010YesNo
17881316METHOD AND SYSTEM FOR ENGAGEMENT OF A SURGICAL TOOL WITH ACTUATORS OF A TOOL DRIVE IN A SURGICAL ROBOTIC SYSTEMAugust 2022May 2025Allow3311NoNo
17817648LASER EYE SURGERY LENS FRAGMENTATIONAugust 2022June 2025Allow3411NoNo
17876224METHODS FOR PHOTODYNAMIC THERAPYJuly 2022February 2023Allow610NoNo
17875266USER INITIATED BREAK-AWAY CLUTCHING OF A ROBOTIC SYSTEMJuly 2022March 2025Allow3201YesNo
17871670DEVICE AND METHOD FOR DILATION OF A TUBULAR ANATOMICAL STRUCTUREJuly 2022December 2023Allow1721NoNo
17870297SYSTEM AND METHOD FOR IMPROVED ELECTRONIC ASSISTED MEDICAL PROCEDURESJuly 2022September 2023Allow1411YesNo
17806675APPARATUS FOR PATTERNED PLASMA-MEDIATED LASER OPHTHALMIC SURGERYJune 2022May 2024Allow2310NoNo
17836479METHODS AND APPARATUS FOR PHOTOTHERAPYJune 2022July 2024Allow2611NoNo
17833908WEARABLE HEMODYNAMIC MONITORING DEVICE AND SYSTEMJune 2022December 2025Allow4211NoNo
17746798METHODS, DEVICES, AND SUPPORT STRUCTURES FOR ASSEMBLING OPTICAL FIBERS IN CATHETER TIPSMay 2022February 2024Allow2100NoNo
17741436SYSTEMS AND METHODS FOR SATURATED ROBOTIC MOVEMENTMay 2022December 2024Allow3120NoNo
17739854IN VIVO IMPLANTABLE NERVE STIMULATION PLATFORM AND NERVE STIMULATION METHOD USING THE SAMEMay 2022January 2026Allow4520NoNo
17701284APPARATUS AND METHOD FOR PROVIDING ENHANCED HEAT TRANSFER FROM A BODYMarch 2022September 2024Allow3020NoNo
17698848INDICATOR FOR TOOL STATE AND COMMUNICATION IN MULTI-ARM ROBOTIC TELESURGERYMarch 2022September 2024Allow3011NoNo
17693494SYSTEM AND APPARATUS FOR TREATING THE LENS OF AN EYEMarch 2022October 2024Allow3120NoNo
17654454Method and Apparatus for Irradiating a Surface with Pulsed LightMarch 2022April 2024Abandon2510NoNo
17691765SYSTEMS AND METHODS FOR MINIMIZING RESPONSE VARIABILITY OF SPINAL CORD STIMULATIONMarch 2022December 2024Allow3320NoNo
17691541PROCESS AND SYSTEM FOR REDUCING LASER DAMAGE TO SURGICAL INSTRUMENTSMarch 2022December 2023Allow2221NoNo
17677974IMAGE GUIDED LASER THERAPYFebruary 2022May 2023Allow1511NoNo
17666153SYSTEMS AND METHODS FOR PREVENTING, MITIGATING, AND/OR TREATING DEMENTIAFebruary 2022January 2025Allow3520YesNo
17632688TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERSFebruary 2022October 2025Allow4411YesNo
17592027COMBINATION TREATMENT USING ELTFebruary 2022August 2022Allow611YesNo
17589222CHARACTERIZING ABLATION LESIONS USING OPTICAL COHERENCE TOMOGRAPHY (OCT)January 2022June 2024Allow2920YesNo
17576902IMAGE GUIDED LASER THERAPYJanuary 2022February 2023Allow1321YesNo
17574970APPARATUS FOR USE IN A SURGICAL PROCEDUREJanuary 2022March 2025Abandon3830NoNo
17572166SYSTEMS AND METHODS FOR PATIENT ALIGNMENT AND TREATMENTJanuary 2022October 2023Allow2110NoNo
17623212CRYOCABIN ARRANGEMENT AND AN OPERATING METHODDecember 2021August 2023Allow2011NoNo
17559947CORNEAL REFRACTIVE CORRECTION USING A SURFACE TREATMENT AFTER CORNEAL RESHAPINGDecember 2021June 2025Allow4211NoNo
17643963TISSUE RESECTION WITH PRESSURE SENSINGDecember 2021November 2024Allow3520YesNo
17547678ROBOTIC SURGICAL SYSTEM FOR INSERTION OF SURGICAL IMPLANTSDecember 2021September 2022Allow1011NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FARAH, AHMED M.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
21.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
2
(20.0%)
Not Allowed After Appeal Filing
8
(80.0%)
Filing Benefit Percentile
26.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner FARAH, AHMED M - Prosecution Strategy Guide

Executive Summary

Examiner FARAH, AHMED M works in Art Unit 3792 and has examined 435 patent applications in our dataset. With an allowance rate of 84.6%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner FARAH, AHMED M's allowance rate of 84.6% places them in the 60% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by FARAH, AHMED M receive 2.09 office actions before reaching final disposition. This places the examiner in the 55% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by FARAH, AHMED M is 35 months. This places the examiner in the 41% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +11.2% benefit to allowance rate for applications examined by FARAH, AHMED M. This interview benefit is in the 46% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 31.2% of applications are subsequently allowed. This success rate is in the 63% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 60.0% of cases where such amendments are filed. This entry rate is in the 85% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 43.8% are granted (fully or in part). This grant rate is in the 36% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.3% of allowed cases (in the 76% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.4% of allowed cases (in the 82% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.